A rally in biotech stocks has raised hopes of a turnaround from the sector’s worst run this century, as drug developers suffered from rising interest rates and a backlash to pandemic-era euphoria.
生物科技股的反彈帶來了該行業扭轉本世紀最糟糕走勢的希望，此前藥物開發商受到了利率上升和對疫情時期興奮情緒反彈的影響。
您已閱讀4%（254字），剩余96%（5514字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。